newsfilter
← Latest News
GlobeNewswire·

Icosavax to Participate in in Upcoming Investor Conferences

SEATTLE, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious